Mersana Therapeutics, Inc. (MRSN) Financials

MRSN Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 226.1 million 189.2 million
2023-09-30 262.9 million 210.7 million
2023-06-30 311.0 million 221.2 million
2023-03-31 296.2 million 231.9 million

MRSN Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -34.5 million 4.1 million
2023-09-30 -46.6 million 4.0 million
2023-06-30 -62.2 million 6.6 million
2023-03-31 -29.9 million 6.4 million

MRSN Net Income

No data available :(

MRSN Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 209.1 million - 8.4 million
2023-09-30 241.0 million - 9.2 million
2023-06-30 286.6 million 25.1 million 10.0 million
2023-03-31 273.9 million 25.0 million 10.7 million

MRSN Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 120.6 million
2023-09-30 120.5 million
2023-06-30 115.6 million
2023-03-31 107.5 million

MRSN Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 386000 21.5 million 10.1 million 447000
2023-09-30 472000 30.5 million 12.9 million -
2023-06-30 399000 49.0 million 18.2 million -
2023-03-31 911000 47.3 million 18.3 million -

MRSN Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 10.7 million 447000
2023-09-30 7.7 million 427000
2023-06-30 10.7 million 324000
2023-03-31 7.8 million 319000

MRSN

Price: $3.40

52 week price:
0.80
9.62

Earnings Per Share: -1.48 USD

P/E Ratio: -2.20

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 915100

Ebitda: -7.8 million

Market Capitalization: 462.2 million

Links: